Stem Cell Factor Deficiency Is Vasculoprotective: Unraveling a New Therapeutic Potential of Imatinib Mesylate
Circulation Research - United States
doi 10.1161/01.res.0000243210.79654.fd
Full Text
Open PDFAbstract
Available in full text
Date
September 15, 2006
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)